Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th March 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Reclassification of pregabalin and gabapentin to Schedule 3
Pregabalin and gabapentin will be reclassified to Schedule 3 drugs from 1 April 2019.
Drugs will be subject to prescription writing requirements 

Pregabalin and gabapentin will be reclassified to Schedule 3 from 1 April 2019, the Veterinary Medicines Directorate has confirmed.

The move comes after experts highlighted increasing numbers of fatalities linked to the drugs, which are used to treat nerve pain, epilepsy and anxiety. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell the drugs to others.

Concerns about the drugs were first raised in 2016 by the Advisory Council on the Misuse of Drugs (ACMD). The group recommended that pregabalin and gabapentin should be controlled as class C Drugs under the Misuse of Drugs Act.

On accepting the advice, the government launched a public consultation to assess the impact on the healthcare sector. Doctors, drug firms, pharmacies and patients all responded to the consultation supporting tighter controls.

Home Office minister Victoria Atkins said: “Any death related to the misuse of drugs is a tragedy. We accepted expert advice and will now change the law to help prevent misuse of pregabalin and gabapentin and addiction to them.

“While drug misuse is lower now than it was 10 years ago, we remain committed to reducing it and the harm it causes. That is why we have published a comprehensive strategy to tackle the illicit drug trade, protect the most vulnerable and help those with drug dependency to recover and turn their lives around.”

From 1 April 2019 Pregabalin and gabapentin will be exempt from safe custody requirements and will be subject to prescription writing requirements. Furthermore, the drugs must be dispensed with 28 days of the prescription being written.

For more information about the reclassification email postmaster@vmd.defra.gsi.gov.uk

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.